What is a Fungating Wound
A fungating wound (also called a malignant fungating wound or MFW) is a secondary chronic wound caused by cancerous cells invading and proliferating through the skin, creating an ulcerating or proliferative lesion that breaks through the skin surface 1, 2.
Key Characteristics
These wounds result from malignant cell proliferation and migration that compromises skin integrity in cancer patients 1. The term "fungating" refers to the characteristic appearance—the wound often has a cauliflower-like or fungus-like growth pattern as tumor cells infiltrate the epidermis and surrounding tissue 3.
Clinical Presentation
Fungating wounds typically present with multiple distressing symptoms:
- Exudate (often copious drainage)
- Malodor (from tissue necrosis and bacterial colonization)
- Bleeding (due to friable, vascular tumor tissue)
- Pain
- Edema
- Visible tumor mass protruding through the skin 4, 2
Underlying Causes and Location
Most commonly associated with:
- Breast cancer (26.7% of cases)
- Cutaneous squamous cell carcinoma (22.8%)
- Vulvar carcinoma (9.9%) 4
Common anatomical locations:
- Head and neck (38.6%)
- Breast/chest wall (29.7%)
- Genitals (9.9%)
- Can occur at primary tumor sites (52.5%) or metastatic sites (22.8%) 4
Clinical Context
These wounds typically occur during advanced or terminal stages of cancer when tumors infiltrate the skin and surrounding tissue 3. They present devastating physical and psychological consequences for patients, significantly impacting quality of life through the combination of visible disfigurement, odor, pain, and continuous drainage 5, 4.
Important Clinical Pitfall
MFWs can be misdiagnosed as abscesses or simple infections, particularly when secondary bacterial infections develop 3. Immunocompromised patients with cancer are especially susceptible to secondary infections (including multidrug-resistant organisms like Pseudomonas aeruginosa) due to disrupted skin barriers and immunosuppression from cancer treatments 3.
Management Implications
The wounds require specialized assessment addressing both wound-related signs (exudate, bleeding, odor, tumor burden) and general symptoms (pain, psychological distress) 1. Radiotherapy achieves treatment goals in 85% of patients and is highly effective for symptom control, particularly in reducing tumor mass, pain, bleeding, and improving wound condition 4. Early involvement of wound care specialists as part of the multidisciplinary oncology team significantly influences how patients adjust to living with these wounds 5.